CorporateInformation.com
 
Company Search:
Advanced Search
 
Featured Products and Services
 
 
Wright Investors Service Perspectives
 
 
 
     
  The Wright Reports site is no longer hosted or operated by Manta. Please review the following:
1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing.
2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com
3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp
4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)
 
     
 
 
 
Wakamoto Pharmaceutical Co., Ltd. Company Snapshot
Business Description:
Wakamoto Pharmaceutical Co., Ltd. operates in the Pharmaceutical preparations sector. WAKAMOTO PHARMACEUTICAL CO., LTD. is a Japan-based pharmaceutical company. The Company operates in four business segments. The Ethical Pharmaceutical segment manufactures and sells ethical pharmaceuticals, including ophthalmology preparation, such as ophthalmic solution, and generic ophthalmic drug used for the treatment of glaucoma and ocular hypertension, as well as auxiliaries for eye surgeries. The Medicine Cosmetics segment manufactures and sells medicated toothpaste and other products. The Special Sales segment sells lactobacillus products and ophthalmic solution to overseas market, as well as active pharmaceutical ingredients (APIs) and other products to domestic market in Japan. The Others segment is engaged in the management of real estate facilities, plant security and afforestation work. In our complete report available for purchase the company is compared to: Medical & Biological Laboratories Company Limited, R-Tech Ueno Limited and Biofermin Pharmaceutical Company Limited.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Wakamoto Pharmaceutical Co., Ltd.
  Stock Performance Chart for Wakamoto Pharmaceutical Co., Ltd.
 
  Stock Data: Recent Stock Performance:
  Current Price (2/3/2012): 236.00
(Figures in Japanese Yen)
1 Week -0.8%   13 Weeks 8.3%  
4 Weeks 1.3%   52 Weeks -7.5%  
 
Wakamoto Pharmaceutical Co., Ltd. Key Data:
  Ticker: 4512 Country: JAPAN
  Exchanges: TYO Major Industry: Drugs, Cosmetics & Health Care
    Sub Industry: Ethical Drug Manufacturers
  2011 Sales 9,669,815,000
(Year Ending Jan 2012).
Employees: 427
  Currency: Japanese Yen Market Cap: 8,213,307,164
  Fiscal Yr Ends: March Shares Outstanding: 34,802,149
  Share Type: Common Closely Held Shares: 16,739,000
 
 
Featured Products and Services
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.